Fuan Pharmaceutical (Group) Co., Ltd. (SHE:300194)
China flag China · Delayed Price · Currency is CNY
4.620
-0.020 (-0.43%)
Jul 25, 2025, 3:11 PM CST

SHE:300194 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Mar '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 2016 - 2020
Net Income
226.39279.84231.87204.61-296.91209.37
Upgrade
Depreciation & Amortization
198.26198.26209.07184.43174.29155.78
Upgrade
Other Amortization
0.960.960.720.970.70.81
Upgrade
Loss (Gain) From Sale of Assets
-0.01-0.01-220.65-4.85-0.31-1
Upgrade
Asset Writedown & Restructuring Costs
37.7737.77228.0625.41827.232.69
Upgrade
Loss (Gain) From Sale of Investments
-77.37-77.37-77.8-62.16-52.47-39.84
Upgrade
Provision & Write-off of Bad Debts
3.963.96-2.433.684.27-1.78
Upgrade
Other Operating Activities
-20.3754.0544.6646.76-286.213.21
Upgrade
Change in Accounts Receivable
46.8446.8471.85-78.5-68.26-75.1
Upgrade
Change in Inventory
-182.31-182.319.2-120.85-65.3-119.29
Upgrade
Change in Accounts Payable
-72.15-72.15-193.15159.8824.9824.92
Upgrade
Change in Other Net Operating Assets
10.0710.074.84.4--
Upgrade
Operating Cash Flow
175.72303.59328.98339.5257.13162.55
Upgrade
Operating Cash Flow Growth
-68.11%-7.72%-3.10%32.04%58.18%-45.01%
Upgrade
Capital Expenditures
-229.3-241.79-215.68-383.1-413.03-344.53
Upgrade
Sale of Property, Plant & Equipment
5.610.3122.674.2831.4971.12
Upgrade
Cash Acquisitions
-----1-201.16
Upgrade
Divestitures
-4.63-4.63--0.06--
Upgrade
Investment in Securities
-59.81-54.81-1.25-71.4332.3852.23
Upgrade
Other Investing Activities
78.1436.10.6410.310.94105.51
Upgrade
Investing Cash Flow
-210-264.83-93.62-440.01-349.24-316.84
Upgrade
Short-Term Debt Issued
-83.04-49.28--
Upgrade
Long-Term Debt Issued
-485.09848.08588.56964.75643.2
Upgrade
Total Debt Issued
873.09568.13848.08637.84964.75643.2
Upgrade
Short-Term Debt Repaid
--37----
Upgrade
Long-Term Debt Repaid
--666.25-706.06-802.42-683-205.22
Upgrade
Total Debt Repaid
-742.59-703.25-706.06-802.42-683-205.22
Upgrade
Net Debt Issued (Repaid)
130.5-135.12142.02-164.58281.75437.98
Upgrade
Common Dividends Paid
-80.66-84.22-93.98-28.09-84.11-72.71
Upgrade
Other Financing Activities
-6.99-8.59-1.7820.9913.77-38.29
Upgrade
Financing Cash Flow
42.85-227.9346.25-171.68211.41326.98
Upgrade
Foreign Exchange Rate Adjustments
0.920.910.882.91-2.17-13.73
Upgrade
Net Cash Flow
9.5-188.26282.49-269.27117.13158.97
Upgrade
Free Cash Flow
-53.5861.8113.3-43.6-155.91-181.98
Upgrade
Free Cash Flow Growth
--45.46%----
Upgrade
Free Cash Flow Margin
-2.61%2.58%4.28%-1.80%-6.35%-7.68%
Upgrade
Free Cash Flow Per Share
-0.050.050.09-0.04-0.13-0.16
Upgrade
Cash Income Tax Paid
159.86202.61198.28155.41190.43213.76
Upgrade
Levered Free Cash Flow
-165.39-37.4898.2-60.74-139.346.66
Upgrade
Unlevered Free Cash Flow
-154.19-22.89116.68-43.91-126.5253.01
Upgrade
Change in Net Working Capital
231.47135.67-7.25-91.15-19.27-130.87
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.